108 results

• Rezurock Lawsuit Claims GVHD Medication Caused Debilitating Skin Condition, Prurigo Nodularis

  June 12, 2026

  Michael Adams

  A California man alleges the GVHD medication Rezurock caused him to develop debilitating prurigo nodularis that disrupted his sleep, ability to wear normal clothing and nursing career.

• Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits

  November 17, 2025

  Irvin Jackson

  Following what it says are promising clinical trial results, Sanofi is seeking yet another approved use for Dupixent, even as concerns grow over the drug's potential link to T-cell lymphoma.

• Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations

  October 29, 2025

  Irvin Jackson

  Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns.

• Federal Appeals Court Returns Zantac Cancer Lawsuits Back To Connecticut State Court

  July 25, 2024

  Irvin Jackson

  An appeals court ruling has approved the transfer of claims representing more than 850 individuals who have filed Zantac cancer lawsuits from federal to state court, over the manufacturers' objections.

• Zantac Lawsuits in Delaware State Court Cleared To Move Forward

  June 3, 2024

  Irvin Jackson

  A Delaware judge has cleared the way for nearly 75,000 Zantac lawsuits to proceed, after rejecting efforts to have plaintiffs' expert witnesses dismissed.

• Jury Rejects Claim That Zantac Caused Cancer Diagnosis in First Bellwether Trial

  May 24, 2024

  Irvin Jackson

  A Chicago jury has turned in a defense verdict in the first Zantac cancer trial, which claimed the recalled heartburn drug caused a woman to develop colorectal cancer.

• Zantac Cancer Risks Concealed By GlaxoSmithKline for Decades, Whistleblower Lawsuit Alleges

  May 21, 2024

  Irvin Jackson

  A whistleblower lawsuit against GlaxoSmithKline claims the company violated state and federal false claims laws by concealing the presence of NDMA, a cancer causing chemical, in the heartburn drug Zantac, which was later removed from the market and reformulated with a different active ingredient.

• Pfizer Zantac Settlement Payouts Will Total Up to $250M for Users Diagnosed with Cancer: Reports

  May 17, 2024

  Irvin Jackson

  Pfizer will pay between $200 million and $250 million to resolve 10,000 Zantac cancer lawsuits filed in various state courts.

• Pfizer Settles 10,000 Zantac Cancer Lawsuits in Latest Deal To Resolve Claims Over Recalled Heartburn Drug

  May 9, 2024

  Irvin Jackson

  A new report indicates Pfizer has reached a deal to settle more than 10,000 Zantac cancer lawsuits filed in state courts nationwide.

• Zantac Jury Trial Over Colorectal Cancer Diagnosis Gets Underway in Illinois

  May 2, 2024

  Irvin Jackson

  A Zantac lawsuit over a colorectal cancer diagnosis will be the first claim to make it before a jury since the heartburn drugs were recalled more than four years ago.